StoneX Group
CABA icon

StoneX Group’s Cabaletta Bio CABA Stock Holding History

StoneX Group’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.1K Buy
+13,415
New +$37.8K ﹤0.01% 1707

Other funds holding CABA

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $493M AUM 21.02% 1-Year Est. Return
MATAURO
MATAURO New York $814M AUM 14.94% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.6B AUM 20.91% 1-Year Est. Return

StoneX Group's CABA Position: Q3 2026 in Review

StoneX Group opened a new position in Cabaletta Bio (CABA) in Q3 2026: 13,415 shares worth $26.1K. The stake represents ﹤0.01% of the portfolio and ranks #1707 among its holdings.

32 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • StoneX Group held 13,415 shares of Cabaletta Bio worth $26.1K as of Q3 2026.
  • Cabaletta Bio was a new StoneX Group position in Q3 2026.
  • Cabaletta Bio made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1707 holding.
  • 32 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.